Emcure Pharmaceuticals has officially incorporated a new wholly-owned subsidiary named Emcure Lifesciences Private Limited, as per its regulatory filing dated June 17, 2025. The move comes after the company earlier announced plans to establish a subsidiary under the proposed name Emcure Generics Private Limited. However, the approved name by the Registrar of Companies (ROC) is Emcure Lifesciences Private Limited.
The subsidiary has been incorporated in Pune, Maharashtra, and will focus on manufacturing, promoting, selling, and distributing pharmaceutical and related products. Emcure has subscribed to 100% of the initial paid-up capital amounting to Rs 1 lakh at a face value of Rs 10 per share, making it a fully owned unit.
The authorized share capital for the newly formed entity stands at Rs 10 crore. This strategic move is aimed at strengthening Emcure’s footprint in the generics and allied pharmaceutical space, aligning with the company’s broader growth objectives.
All other aspects of the original disclosure from May 22, 2025—including the business objectives—remain unchanged apart from the name.
Ahmedabad Plane Crash